TDF Litigation - HIV Lawsuit
Kidney Damage and Broken Bones for HIV-Positive Patients: Caused by Drug Company Greed
Truvada, Atripla, Complera, Viread, and Stribild Have Side Effects that are Dangerous and Unnecessary
If you or someone you care for has taken one or more of the HIV/AIDS drugs Truvada, Atripla, Complera, Viread, or Stribild, you may have an unnecessary increased risk of permanent or fatal damage to your kidneys and/or bones. This risk, although well known and discussed, may be due to drug company fraud and potentially could have been avoided.
Contact our office right away at 409-763-3260 if you have taken one or more of these drugs, either for PrEP or treatment, and you have suffered from any of the following:
chronic kidney disease,
impaired kidney function,
acute kidney injury (AKI),
acute renal failure (ARF),
Bone breaks and fractures
You may be eligible for compensation for your injuries, but you must contact the Law Offices of Craig Eiland at 409-763-3260 quickly for a free consultation to learn about your rights.
Gilead Sciences hid the safer version of its HIV drugs to increase profits.
Gilead Sciences, Inc. is a pharmaceutical company best known for making and selling the HIV treatment and prevention drugs Truvada, Atripla, Complera, Viread, and Stribild. While these drugs can be effective and helpful for HIV-positive patients and as a preventive measure, new information is coming to light suggesting that two major side-effects: Kidney Damage and Loss of Bone Mineral Density, are risks that could and should have been avoided.
The active ingredient in Truvada, Atripla, Complera, Viread, and Stribild is tenofovir disoproxil fumarate (“TDF”). Gilead has known since the 1990s that this drug, TDF, had toxic effects on the kidney and bones of patients who would take it. At the same time Gilead was developing TDF in the 1990s, it was also working on TAF, a slightly different form of the drug. TAF is much more potent and effective than TDF and because of its potency, TAF can be given in a lower dose…which exposes the kidneys and bones to less of the toxic effects.
Court documents allege that the company recognized that TAF was safer, but they shelved the safer drug and proceeded with putting TDF on the market first. This way, after the patent on TDF expired, they could then come in with a “new and improved” drug, TAF, get new patents, and make more money. Gilead understood that if it started with the safer, more potent TAF first, there would be no improvement later by offering TDF.
Some in the pharmaceutical industry call this “product pipeline management!” We say it is inconceivable and irresponsible!
If these allegations are true, then the kidney and bone side effects suffered by you or your loved one may have been avoided. The Law Offices of Craig Eiland is investigating these claims and we are prepared to work on your behalf to uncover the truth and represent you in a legal claim if necessary. Our attorneys have decades of combined experience in pharmaceutical drug litigation and we handle our cases with the care and attention.
The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.